university of Tampere
Tampere, 33014, Finland
NCT Number: NCT00973583
The investigators earlier clinical study in 754 young Finnish men demonstrated a significant negative association of serum 25-OHD concentration with acute respiratory tract infections. The present study aimed to determine whether vitamin D supplementation may decrease the incidence of acute respiratory tract infections.
Looking for future studies?
Notify MeMale
Interventional
Not applicable
Tampere, 33014, Finland
Subjects comprised 164 male conscripts at a military base in Finland. Half of the participants were randomly allocated to receive 400 IU vitamin D daily and half received placebo from October through March. Serum vitamin D and plasma parathyroid hormone concentrations were determined. Subjects were followed for 6 months and the primary outcome was the number of days absent from duty due to ARTI.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
vitamin D3 400 IU daily
Other names: Minisun
placebo
Other names: Pharmia, Finland
Time frame: 6 months
Time frame: 6 months
Time frame: 6 months
Tampere University
Other
Vitamin D Supplementation for the Prevention of Acute Respiratory Tract Infections; a Randomized Double-blinded Trial in Young Finnish Men
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05422326
Animal Diseases, Bird Diseases
Huntsville, Alabama, United States
View Trial DetailsNCT06149494
COPD, COPD Exacerbation Acute
London, United Kingdom
View Trial DetailsNCT01906853
Allergy, Dermatitis
Heidelberg, Victoria, Australia
View Trial DetailsNCT05875961
Infection Viral, Infections
Rockville, Maryland, United States
View Trial Details